Παρασκευή 22 Απριλίου 2016

Low Ratio of Treg to Th17 Cells After 36 Weeks of Telbivudine Therapy Predict HBeAg Seroconversion

Viral Immunology , Vol. 0, No. 0.


from Allergy\Immunology via ola Kala on Inoreader http://ift.tt/1VMnR4G
via IFTTT



from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1SoHGJA
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου